Skye Bioscience, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Skye Bioscience, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Skye Bioscience, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $185K, a 27.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $185K -$70K -27.5% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $203K -$67.6K -25% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $221K +$170K +336% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $238K +$167K +234% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $255K +$163K +180% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $271K +$160K +145% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $50.7K -$78.3K -60.7% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $71.2K -$75.8K -51.6% Dec 31, 2022 10-K 2024-03-22
Q3 2022 $91.1K -$73.6K -44.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $110K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $129K Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $147K +$147K Dec 31, 2021 10-K 2023-03-31
Q3 2021 $165K Sep 30, 2021 10-Q 2021-11-10
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.